Aster DM Healthcare Limited has issued a clarification regarding a media release dated December 18, 2025, which announced a proposed ₹125 crore healthcare development project in Kottakkal, Kerala. The company wishes to clarify that this proposed investment is contingent upon obtaining relevant corporate approvals, including the approval of the Board of Directors of Aster DM Healthcare Limited and its subsidiary, M/s. Malabar Institute of Medical Sciences Limited. Aster DM Healthcare stated that further disclosures will be made as appropriate once the requisite corporate approvals are secured for the proposed investment, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and other applicable provisions. This clarification is provided to ensure transparent communication with stakeholders, and investors and market participants are advised to take note of this information.